JPS5821639B2 - １，３− サンソカ ８ アルフア − エストラトリエンノ セイホウ - Google Patents

１，３− サンソカ ８ アルフア − エストラトリエンノ セイホウ

Info

Publication number
JPS5821639B2
JPS5821639B2 JP49080116A JP8011674A JPS5821639B2 JP S5821639 B2 JPS5821639 B2 JP S5821639B2 JP 49080116 A JP49080116 A JP 49080116A JP 8011674 A JP8011674 A JP 8011674A JP S5821639 B2 JPS5821639 B2 JP S5821639B2
Authority
JP
Japan
Prior art keywords
group
estra
methyl
general formula
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49080116A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5032160A (en, 2012
Inventor
クラウス・プレツエヴオヴスキー
フリートムント・ノイマン
ヘルムート・ホーフマイステル
ヘンリー・ラウレント
ユキシゲ・ニシノ
ルードルフ・ヴイーヘルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5032160A publication Critical patent/JPS5032160A/ja
Publication of JPS5821639B2 publication Critical patent/JPS5821639B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
JP49080116A 1973-07-13 1974-07-12 １，３− サンソカ ８ アルフア − エストラトリエンノ セイホウ Expired JPS5821639B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (2)

Publication Number Publication Date
JPS5032160A JPS5032160A (en, 2012) 1975-03-28
JPS5821639B2 true JPS5821639B2 (ja) 1983-05-02

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49080116A Expired JPS5821639B2 (ja) 1973-07-13 1974-07-12 １，３− サンソカ ８ アルフア − エストラトリエンノ セイホウ

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en, 2012)
AT (1) ATA575574A (en, 2012)
AU (1) AU477010B2 (en, 2012)
CA (1) CA1030951A (en, 2012)
CH (2) CH614217A5 (en, 2012)
CS (2) CS182260B2 (en, 2012)
DD (1) DD114066A5 (en, 2012)
DK (1) DK133051C (en, 2012)
ES (1) ES428226A1 (en, 2012)
FI (1) FI54131C (en, 2012)
FR (1) FR2236505B1 (en, 2012)
GB (1) GB1479934A (en, 2012)
HU (1) HU169791B (en, 2012)
IE (1) IE39872B1 (en, 2012)
IL (1) IL45259A (en, 2012)
NO (1) NO742546L (en, 2012)
SE (1) SE7409151L (en, 2012)
SU (1) SU626705A3 (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト

Also Published As

Publication number Publication date
SU626705A3 (ru) 1978-09-30
AU7112374A (en) 1976-01-15
IE39872B1 (en) 1979-01-17
IE39872L (en) 1975-01-13
DK368074A (en, 2012) 1975-03-17
FR2236505B1 (en, 2012) 1977-07-08
IL45259A0 (en) 1974-10-22
SE7409151L (sv) 1975-01-14
ES428226A1 (es) 1976-07-16
DK133051B (da) 1976-03-15
CH609064A5 (en) 1979-02-15
CS182260B2 (en) 1978-04-28
AU477010B2 (en) 1976-10-14
NO742546L (en, 2012) 1975-02-10
CA1030951A (en) 1978-05-09
HU169791B (en) 1977-01-28
DD114066A5 (en, 2012) 1975-07-12
DK133051C (da) 1976-08-16
GB1479934A (en) 1977-07-13
ATA575574A (de) 1978-05-15
FI54131C (fi) 1978-10-10
FI54131B (fi) 1978-06-30
CH614217A5 (en) 1979-11-15
JPS5032160A (en, 2012) 1975-03-28
FI213974A7 (en, 2012) 1975-01-14
CS182300B2 (en) 1978-04-28
FR2236505A1 (en, 2012) 1975-02-07
IL45259A (en) 1977-10-31

Similar Documents

Publication Publication Date Title
EP1272504B1 (de) 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene
AU4401100A (en) Ent-steroids as selectively active estrogens
CA1109458A (en) 11.beta.-SUBSTITUTED STEROIDS
US3166577A (en) 1, 2-dimethyl estrogens and intermediates used in the production thereof
JPS5821639B2 (ja) １，３− サンソカ ８ アルフア − エストラトリエンノ セイホウ
IE902941A1 (en) 4-SUBSTITUTED 17ß-(CYCLOPROPYLOXY)ANDROST-5-EN-3ß-OL AND¹RELATED COMPOUNDS USEFUL AS C17-20 LYASE INHIBITORS
GB1569135A (en) Steroids
CA1076102A (en) Estradiol derivatives
US3951958A (en) 1,3-Oxygenated-8α-estratrienes
US3951959A (en) 1,3-Oxygenated 8α-estratrienes
CS205009B2 (en) Process for preparing 7-hydroxyestradioles
US3960841A (en) 3,17,18-Trihydroxy-1,3,5(10)-estratrienes
JPH0515720B2 (en, 2012)
US3377365A (en) (optionally 17-alkylated) 11beta, 13beta-dialkylgona-1, 3, 5(10)-triene-3, 17beta-diols, ethers and esters thereof
KR970005317B1 (ko) 19-노르 프로게스테론의 유도체, 이들을 생성시키는 방법 및 이들을 혼입시킨 제약조성물
JPH03218393A (ja) １４，１７α―エテノ―および―エタノエストラトリエン、その製造方法およびこれを含有するエストロゲンが誘因のまたはエストロゲンから誘導される疾患の治療のための医薬品
US5529993A (en) 14α, 17α-ethano-16α-hydroxy-estratrienes
DE10019167A1 (de) Substituierte Estratriene als selektiv wirksame Estrogene
US3470159A (en) Estra-1,3,5(10),7-tetraenes and process of preparation
US3076826A (en) 17 alpha-(lower-alkyl)-19-nor-5(10)-androstene-3, 17beta-diols
US3080399A (en) Cyclopentanophenanthrene compounds and process
TW390886B (en) Medrogestone, its intermediates and the processes for the production thereof
Hirschmann et al. Inversions of both adjacent centers in the formolysis of a 2, 2, 6-trialkylcyclohexyl tosylate. Formation of a 13. alpha.-D-homo steroid
JPS6211000B2 (en, 2012)
NO140679B (no) Fremgangsmaate for fremstilling av alfa-1, 6-glukosidaser